![]() |
市場調查報告書
商品編碼
1954634
全球醫療器材洩漏測試市場:市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的分析及預測(2026-2034 年)Medical Device Leak Testing Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
全球醫療器材洩漏測試市場呈現強勁成長勢頭,主要受醫療器材產量不斷增長以及產品安全和品質保證方面日益嚴格的監管要求的推動。根據 2025 年的報告,該市場在 2025 年的價值為 5.4182 億美元,預計到 2026 年將成長至 5.9903 億美元。到 2034 年,市場規模預計將達到 17.1482 億美元,在預測期(2026-2034 年)內將維持 14.05% 的複合年增長率。 預計到2025年,亞太地區將以44.40%的市場佔有率引領全球市場,這反映了該地區醫療器材製造基地的不斷擴大。
市場概覽
醫療器材洩漏測試是檢測導管、血袋、植入式器械、呼吸器和其他關鍵器械洩漏的重要品質控管程序。洩漏檢測可確保產品完整性、病患安全以及在商業化之前符合監管要求。根據器械類型和應用領域(例如心臟病學、泌尿外科、骨科和微創手術),會採用不同的測試方法。
隨著全球慢性病發生率的上升,診斷和治療程序激增,促使對醫療器材的需求增加。產量的成長直接促進了製造工廠對洩漏測試系統的採用。
新冠疫情的影響
新冠疫情對醫療器材洩漏測試市場產生了正面影響。 2020年,呼吸器、導管和其他重要醫療設備的需求顯著成長。多家製造商擴大了產能以滿足緊急醫療需求。例如,飛利浦在2020年將其呼吸器產能翻了一番。隨著產量的增加,全球範圍內進行的洩漏測試數量也顯著增長。
儘管由於疫情高峰期的大規模採購,2021年洩漏測試數量略有下降,但對洩漏測試解決方案的總體需求依然強勁,支撐著市場的長期擴張。
市場趨勢
影響市場發展的關鍵趨勢之一是區域性洩漏測試服務提供者數量的增加。由於洩漏測試系統的安裝和維護成本較高,許多中小型製造商選擇將測試服務外包。 這種轉變促使全球湧現新的服務提供者。
此外,製造商正在加速部署具有更高自動化和整合能力的先進洩漏測試儀,以滿足不斷變化的生產需求。
市場成長驅動因素
主要成長驅動因素是全球醫療器材產量的成長。 心血管、泌尿和骨科病例的增加正在加速對導管、植入式設備和手術器械的需求。
例如,英國約有 9 萬人使用導管,全球數百萬名患者依賴植入式心臟節律器。 製造設施的擴建,包括新建導管生產廠,進一步增加了對洩漏測試設備的需求。
此外,洩漏測試儀在製造現場的廣泛應用(據估計全球已有數十萬台)表明其滲透率很高,且採用率還在不斷提高。
限制因子
儘管市場成長強勁,但由於洩漏測試儀成本高昂,市場仍面臨挑戰。先進的系統,例如氦氣和氫氣示踪氣體測試設備,需要大量投資,這限制了中小製造商,特別是新興經濟體製造商的採用。 安裝、校準和維護成本會進一步增加營運成本。
市場區隔分析
依測試類型
該市場依測試類型細分為壓力衰減法、真空衰減法、示踪氣體法和其他方法。
由於壓力衰減法操作簡單、易於自動化以及易於整合到裝配線中,預計到2026年,其市場佔有率將達到43.73%,位居榜首。真空衰減法和示踪氣體法也因其在提高精度和符合法規要求方面的優勢而日益普及。
依應用領域
應用領域包括心臟病學、泌尿科、骨科、微創/一般外科、糖尿病護理等。
預計到2026年,泌尿外科領域將佔30.52%的市場佔有率,這主要得益於導尿管使用量和泌尿外科手術量的增加。 隨著心臟節律器和植入式醫療器材的日益普及,心臟病學領域也不斷擴張。
依產品類型劃分
市場區隔包括導管、血液相關器材、血袋、植入式醫療器材、大型設備等。
在產品頻繁上市和全球高使用率的推動下,導管細分市場預計將在2026年佔33.48%的市場佔有率。 更嚴格的上市前洩漏驗證監管要求進一步推動了該領域的成長。
亞太地區
亞太地區在2025年以2.4054億美元的市場規模領跑,預計到2026年將達到2.6711億美元。成長主要受醫療器材生產擴張、微創手術增多以及監管要求的推動。
北美
北美地區持續保持穩定成長,這得益於該地區心血管疾病和泌尿系統疾病的高發生率,以及眾多領先的洩漏測試公司對先進技術的投資。
歐洲
在歐洲,人口老化和骨科手術的增加推動了對可靠洩漏測試解決方案的需求成長,預計該地區市場也將成長。
其他地區
其他地區由於監管意識的提高和醫療器材製造領域研發投入的增加,正經歷著溫和增長。
The global medical device leak testing market is witnessing robust growth, driven by the rising production of medical devices and stringent regulatory requirements for product safety and quality assurance. According to the 2025 report, the market was valued at USD 541.82 million in 2025 and is projected to grow to USD 599.03 million in 2026. By 2034, the market is expected to reach USD 1,714.82 million, registering a strong CAGR of 14.05% during the forecast period (2026-2034). In 2025, Asia Pacific dominated the global market with a 44.40% share, reflecting the region's expanding medical device manufacturing base.
Market Overview
Medical device leak testing is a mandatory quality control procedure used to detect leaks in devices such as catheters, blood bags, implantable devices, ventilators, and other critical equipment. Leak detection ensures product integrity, patient safety, and regulatory compliance before commercialization. Various testing methods are used depending on the device type and application area, including cardiology, urology, orthopedics, and minimally invasive surgery.
The increasing prevalence of chronic diseases worldwide has led to a surge in diagnostic and therapeutic procedures, which in turn has boosted the demand for medical devices. This expanding production volume directly contributes to higher adoption of leak testing systems across manufacturing facilities.
COVID-19 Impact
The COVID-19 pandemic had a positive impact on the medical device leak testing market. During 2020, the demand for ventilators, catheters, and other essential medical equipment surged significantly. Several manufacturers increased production capacity to meet urgent healthcare needs. For instance, Philips doubled its ventilator production capacity in 2020. The higher production volumes resulted in a substantial increase in the number of leak tests performed globally.
Although there was a slight decline in 2021 due to bulk procurement during the peak pandemic phase, overall demand for leak testing solutions remained strong, supporting long-term market expansion.
Market Trends
One of the key trends shaping the market is the growing number of regional leak testing service providers. Due to the high installation and maintenance costs of leak testing systems, many small and mid-sized manufacturers are outsourcing testing services. This shift has led to the emergence of new service providers globally.
Additionally, manufacturers are increasingly launching advanced leak testers with improved automation and integration capabilities to meet evolving production requirements.
Market Growth Drivers
The primary growth driver is the rising production of medical devices worldwide. Increasing cases of cardiovascular, urological, and orthopedic disorders are accelerating the demand for catheters, implantable devices, and surgical equipment.
For example, approximately 90,000 people use catheters in the U.K., and millions of patients globally rely on implantable pacemakers. Expanding manufacturing facilities, such as new catheter production plants, are further increasing the demand for leak testing equipment.
Moreover, the widespread installation of leak testers across manufacturing units-estimated in hundreds of thousands globally-demonstrates strong penetration and growing adoption.
Restraining Factors
Despite strong growth, the market faces challenges due to the high costs associated with leak testing equipment. Advanced systems such as helium and hydrogen-based tracer gas testers require significant investment, limiting adoption among small manufacturers, especially in emerging economies. Installation, calibration, and maintenance expenses further add to operational costs.
Market Segmentation Analysis
By Test Type
The market is segmented into pressure decay, vacuum decay, tracer gas, and others.
The pressure decay segment held the largest share of 43.73% in 2026, driven by its simplicity, automation compatibility, and easy integration into assembly lines. Vacuum decay and tracer gas testing methods are also gaining traction due to improved accuracy and regulatory compliance advantages.
By Application
Based on application, the market includes cardiology, urology, orthopedics, minimally invasive/general surgery, diabetes care, and others.
The urology segment accounted for 30.52% share in 2026, supported by rising catheter usage and urological procedures. Cardiology is also expanding due to growing adoption of pacemakers and implantable devices.
By Product Type
The market is segmented into catheters, blood devices, bags, implantable devices, capital equipment, and others.
The catheters segment dominated with a 33.48% share in 2026, owing to frequent product launches and high global usage rates. Increasing regulatory requirements for pre-market leak validation further strengthen segment growth.
Asia Pacific
Asia Pacific led the market in 2025 with USD 240.54 million, and the regional market reached USD 267.11 million in 2026. Growth is fueled by expanding medical device production, rising minimally invasive surgeries, and regulatory mandates.
North America
North America continues to grow steadily due to high prevalence of cardiovascular and urological disorders, along with strong presence of major leak testing companies launching advanced technologies.
Europe
Europe is witnessing growth driven by an aging population and increasing orthopedic procedures, boosting demand for reliable leak testing solutions.
Rest of the World
Other regions are experiencing gradual growth due to increasing regulatory awareness and growing R&D investments in medical device manufacturing.
Competitive Landscape
The market is semi-consolidated, with major players such as ATEQ Leaktesting, Cincinnati Test Systems, Pfeiffer Vacuum GmbH, InterTech Development Company, Uson L.P., Zaxis Inc., FasTest, and LACO Technologies. These companies are focusing on product innovation, partnerships, facility expansions, and geographic expansion to strengthen their market position.
Recent developments include facility expansions, product upgrades, and strategic collaborations aimed at enhancing leak detection capabilities and global outreach.
Conclusion
The global medical device leak testing market is positioned for substantial expansion, growing from USD 541.82 million in 2025 to USD 599.03 million in 2026, and projected to reach USD 1,714.82 million by 2034 at a CAGR of 14.05%. Rising medical device production, stringent regulatory standards, increasing chronic disease prevalence, and technological advancements in leak detection systems are the primary forces driving market growth worldwide.
Segmentation By Test Type
By Application
By Product Type
By Region